#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4734806	ADME	Substrate activity at FAAH in FAAH+/+ mouse brain assessed as N-arachidonoyl conjugate level per g protein at 0.1 mM measured after 20 mins by LC-MS/MS analysis	Mus musculus	6	ALA4732106	tissue-based format	Scientific Literature
2.	ALA4734807	ADME	Prodrug conversion in FAAH-/- mouse brain assessed as N-arachidonoyl conjugate level per g protein at 0.1 mM measured after 20 mins by LC-MS/MS analysis	Mus musculus	6	ALA4732106	tissue-based format	Scientific Literature
3.	ALA4734810	ADME	Prodrug conversion in FAAH+/+ mouse brain assessed as N-arachidonoyl conjugate level per g protein at 100 mg/kg, ip measured after 20 mins by LC-MS/MS analysis	Mus musculus	5	ALA4732106	organism-based format	Scientific Literature
4.	ALA4734812	ADME	Prodrug conversion in FAAH-/- mouse brain assessed as N-arachidonoyl conjugate level per g protein at 100 mg/kg, ip measured after 20 mins by LC-MS/MS analysis	Mus musculus	5	ALA4732106	organism-based format	Scientific Literature
5.	ALA4734814	Functional	Antinociceptive activity in ip dosed C57BL/6 mouse assessed as reduction in licking time during first phase treated for 10 mins and measured for 5 mins by formalin test	Mus musculus	2	ALA4732106	organism-based format	Scientific Literature
6.	ALA4734815	Functional	Antinociceptive activity in ip dosed C57BL/6 mouse assessed as reduction in licking time during second phase treated for 10 mins and measured for 15 to 40 mins by formalin test	Mus musculus	2	ALA4732106	organism-based format	Scientific Literature
7.	ALA4734816	ADME	Effect on locomotor activity in C57BL/6 mouse assessed as change in latency to fall at 50 to 75 mg/kg, ip treated for 10 mins measured up to 60 mins by rotarod test	Mus musculus	1	ALA4732106	organism-based format	Scientific Literature
8.	ALA4734818	Functional	Antinociceptive activity in C57BL/6 mouse assessed as reduction in licking time during second phase at 50 mg/kg, ip treated for 10 mins and measured for 15 to 40 mins in presence of FAAH inhibitor URB937 by formalin test	Mus musculus	1	ALA4732106	organism-based format	Scientific Literature
9.	ALA4734819	Functional	Antinociceptive activity in C57BL/6 mouse assessed as reduction in licking time during second phase at 50 mg/kg, ip treated for 10 mins and measured for 15 to 40 mins in presence of TRPV1 antagonist capsazepine by formalin test	Mus musculus	1	ALA4732106	organism-based format	Scientific Literature
10.	ALA4734824	Functional	Antinociceptive activity in C57BL/6 mouse assessed as reduction in licking time during first phase at 50 mg/kg, ip treated for 10 mins and measured for 5 mins in presence of FAAH inhibitor URB937 by formalin test	Mus musculus	1	ALA4732106	organism-based format	Scientific Literature
11.	ALA4734825	Functional	Antinociceptive activity in C57BL/6 mouse assessed as reduction in licking time during first phase at 50 mg/kg, ip treated for 10 mins and measured for 5 mins in presence of TRPV1 antagonist capsazepine by formalin test	Mus musculus	1	ALA4732106	organism-based format	Scientific Literature
12.	ALA4734849	Toxicity	Hepatotoxicity in C57BL/6 mouse assessed as change in ALT level at 300 mg/kg, ip measured after 12 hrs	Mus musculus	5	ALA4732106	organism-based format	Scientific Literature
13.	ALA4734851	Toxicity	Hepatotoxicity in C57BL/6 mouse assessed as centrilobular necrosis at 300 mg/kg, ip measured after 12 hrs by H and E staining based microscopic analysis	Mus musculus	5	ALA4732106	organism-based format	Scientific Literature